20. Risk Factors for Breakthrough Cytomegalovirus (CMV) Infection and De Novo Resistance in Hematopoietic Cell Transplantation (HCT) Recipients Receiving Letermovir Prophylaxis

BACKGROUND: Subclinical CMV reactivation on letermovir prophylaxis may be important for CMV-specific immune reconstitution after HCT (Zamora et al. Blood 2021) but concerns remain regarding the development of antiviral resistance. Here we analyze risk factors associated with breakthrough CMV infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamora, Danniel, Perchetti, Garrett, Biernacki, Melinda, Xie, Hu, Castor, Jared L, Joncas-schronce, Laurel, Blazevic, Rachel, Leisenring, Wendy, Huang, Meei-Li, Jerome, Keith, Martin, Paul J, Boeckh, Michael, Greninger, Alexander L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643935/
http://dx.doi.org/10.1093/ofid/ofab466.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643935/
http://dx.doi.org/10.1093/ofid/ofab466.020

Ejemplares similares